Re-treatment of chronic hepatitis C with consensus interferon .
about
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis CChronic viral hepatitis C: management updateChronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP).Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial.Methodological issues in papers on IFN therapy: time for reappraisal.Hepatitis C: retreatment and treatment of patients with renal failure.Treatment of hepatitis C with interferon and ribavirin.Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.Experimental and emerging therapies for chronic hepatitis C virus infection.The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.Effect of pegylated interferon on non-responders and relapsers with interferon.Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells.Retreatment of chronic hepatitis C in previous non-responders and relapsers.Old and emerging therapies in chronic hepatitis C: an update.Managing pediatric hepatitis C: current and emerging treatment options.Consensus interferon plus ribavirin for hepatitis C genotype 3 patients previously treated with pegylated interferon plus ribavirin.Review of consensus interferon in the treatment of chronic hepatitis C.Interferon combination therapy for HIV/hepatitis C virus coinfection.Retreatment of patients nonresponsive to pegylated interferon and ribavirin with daily high-dose consensus interferon.Spectrum of virus inhibition by consensus interferon YM643.Long-term retreatment in chronic hepatitis C patients who were non-responders to an initial course of interferon-alpha 2b.The natural course of chronic hepatitis C: implications for clinical practice.Consensus interferon: a novel interferon for the treatment of hepatitis C.A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 group.The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C.Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2.A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.Efficacy of consensus interferon in the treatment of chronic hepatitis C.Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype.Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.Management of chronic hepatitis C treatment failures: role of consensus interferon.A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon.[Hepatitis C]Chronic hepatitis C
P2860
Q24201588-6664503D-42CC-4A23-9E72-5C6B641DE734Q27471844-FF173B9E-FA23-4473-914F-B964F2D86E20Q30580854-E1D0BA36-D96A-4CD3-BECA-1EE31422F62FQ33866324-82F8F0FB-F1BA-41EF-BCC2-0FFB32802A74Q33940500-36FEAF57-1C97-40F4-8A3F-9B7080E55504Q33988112-ECA13F3D-D4CA-4F54-84C4-594F3394CD5BQ33988146-7443D067-18B0-47DE-9FA8-6B2675D09EE4Q34129547-4EF1561E-8A57-4807-867D-382F0DE2A0F9Q34481629-A4CAED88-22BE-41DE-936E-9FCB4CAAA01FQ34996746-7BF3E8C2-DCA6-4879-9F99-83238056EAC9Q35041900-B0D6AE38-4ACD-4CB9-A47E-C03966325AEBQ35217294-EB61C726-AA5A-4C3A-A7FB-1556975932DAQ36740258-D9DF6C36-1C2D-4F46-82AF-9485B8F9EEEAQ36968144-37EF57E4-DADC-40FD-AE49-054B77792BCAQ37035294-9E3A5562-1971-4B8F-A6AA-4C78731CA86AQ37316248-E69FC435-68E7-4D82-8D56-F648047F4F7DQ37401164-91A1D883-938D-40EE-82D0-4E1A43B27F4DQ37586950-ED8AD19A-57B8-4E5E-ADE4-10787F6CCA55Q37931258-8BCD7E14-1EDA-4B8D-84DE-367D5E8B488EQ39801030-9EEFC0BD-057E-44A1-959F-E88137D4C3EEQ40609920-94287A2B-D03C-4992-83C9-D83D1C2E2114Q42990653-3726DD6B-8B66-414A-B79D-EC6105FCDFABQ42990670-3A2857C2-909F-42BE-B486-2083EE400ADEQ42990674-8E3FA62A-F28C-48AD-B227-4BA2800D15B1Q42996612-02C8AE97-AA97-4EB4-8EF0-3F4B047C6373Q42996800-D2BE25A7-49BA-496E-ACE3-CCD96FF91F06Q42999278-C8ED7044-460B-4200-BB79-EA14496F6D36Q42999698-87BE2451-CD0B-4F5A-A39A-502365EB6DD3Q43001230-9CAFE805-EA52-4F0E-B3C9-B02FC6155594Q43029839-A4886D49-D976-401C-B04C-871794244015Q43029858-71460A5C-5A8B-48B4-B52D-600C9C23E761Q43040099-5D623B12-EE5B-49DF-9ACD-DBA07A86488DQ43071210-6A4C0C89-8E50-4DEB-9790-B6FD6FDB6577Q50584912-D1F6AE6E-2900-45A9-8855-9FC54B987C0AQ50585927-C3088F1A-4A95-45C6-BAB9-87E4DD562592Q56929229-E62A2DE0-B740-442F-9EA8-7BAECA516A2A
P2860
Re-treatment of chronic hepatitis C with consensus interferon .
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Re-treatment of chronic hepatitis C with consensus interferon .
@en
Re-treatment of chronic hepatitis C with consensus interferon .
@nl
type
label
Re-treatment of chronic hepatitis C with consensus interferon .
@en
Re-treatment of chronic hepatitis C with consensus interferon .
@nl
prefLabel
Re-treatment of chronic hepatitis C with consensus interferon .
@en
Re-treatment of chronic hepatitis C with consensus interferon .
@nl
P2093
P356
P1433
P1476
Re-treatment of chronic hepatitis C with consensus interferon .
@en
P2093
D G Albert
E B Keeffe
E J Heathcote
S V Feinman
P304
P356
10.1002/HEP.510270431
P407
P577
1998-04-01T00:00:00Z